Search Results - Gilles Vassal

Refine Results
  1. 1
    Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents

    Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents by Gilles Vassal, Teresa de Rojas, Andrew D.J. Pearson

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma

    Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma by Eric Baudin, Gabriella Pellegriti, M. Bonnay, A. Penfornis, A. Laplanche, Gilles Vassal, Martin Schlumberger

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    High Levels of Circulating VEGFR2+ Bone Marrow–Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies

    High Levels of Circulating VEGFR2+ Bone Marrow–Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies by Mélissa Taylor, Jochen Rößler, Birgit Geoerger, Agnès Laplanche, Olivier Hartmann, Gilles Vassal, Françoise Farace

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Precision Oncology: a Clinical and Patient Perspective

    Precision Oncology: a Clinical and Patient Perspective by Ulrik Lassen, Lydia Makaroff, Albrecht Stenzinger, Antoîne Italiano, Gilles Vassal, Jesús García‐Foncillas, Bernard Avouac

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    The selective VEGFR1‐3 inhibitor axitinib (AG‐013736) shows antitumor activity in human neuroblastoma xenografts

    The selective VEGFR1‐3 inhibitor axitinib (AG‐013736) shows antitumor activity in human neuroblastoma xenografts by Jochen Rößler, Yann Monnet, Françoise Farace, Paule Opolon, Estelle Daudigeos‐Dubus, Abderrahmane Bourredjem, Gilles Vassal, Birgit Geoerger

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?

    Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? by Gilles Vassal, Alain Deroussent, Dominique Challine, O Hartmann, Serge Koscielny, Dominique Valteau‐Couanet, J Lemerle, Alain Gouyette

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Busulfan disposition below the age of three: alteration in children with lysosomal storage disease

    Busulfan disposition below the age of three: alteration in children with lysosomal storage disease by Gilles Vassal, Alain Fischer, Dominique Challine, I Boland, F Ledheist, S. Lemerle, E Vilmer, C Rahimy, G Souillet, Éliane Gluckman

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution

    Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 pati... by Oliver Hartmann, D Valteau-Couanet, Gilles Vassal, V. Lapierre, Laurence Brugières, Rafaël Delgado, D. Couanet, J. Lumbroso, E Benhamou

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma

    Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma by Julie Liberman, Hervé Sartelet, Marjorie Flahaut, Annick Mühlethaler‐Mottet, Aurélie Coulon, Carine Nyalendo, Gilles Vassal, Jean‐Marc Joseph, Nicole Groß

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors

    Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors by Estelle Daudigeos‐Dubus, Ludivine Le Dret, Olivia Bawa, Paule Opolon, Albane Vievard, Irène Villa, Jacques Bosq, Gilles Vassal, Birgit Geoerger

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma

    Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma by Nathalie Gaspar, Swee Y. Sharp, Suzanne A. Eccles, Sharon Gowan, Sergey Popov, Chris Jones, Andrew D.J. Pearson, Gilles Vassal, Paul Workman

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model

    Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model by Frank Griscelli, Hong Li, Chiat Cheong, Paule Opolon, Annelise Bennaceur‐Griscelli, Gilles Vassal, Jeannette Soria, Claudine Soria, Lu H, Michel Perricaudet, Patrice Yeh

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

    Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors by Catherine Delbaldo, Étienne Chatelut, Micheline Ré, Alain Deroussent, Sophie Séronie-Vivien, A. Jambu, P. Berthaud, Axel Le Cesne, Jean‐Yves Blay, Gilles Vassal

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (17-AAG, Tanespimycin) in Glioblastoma Cells

    Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (17-AAG, Tanespimycin) in Glioblastoma Cells by Nathalie Gaspar, Swee Y. Sharp, Simon Pacey, Chris Jones, Michael I. Walton, Gilles Vassal, Suzanne A. Eccles, Andrew D.J. Pearson, Paul Workman

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

    Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts by Birgit Geoerger, Jacques Grill, Paule Opolon, Jackie Morizet, Geneviève Aubert, Yann Lécluse, Victor W. van Beusechem, Winald R. Gerritsen, David H. Kirn, Gilles Vassal

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Autophagy is associated with chemoresistance in neuroblastoma

    Autophagy is associated with chemoresistance in neuroblastoma by Assila Belounis, Carine Nyalendo, Roxane Le Gall, Tina V. Imbriglio, Mohamed Mahma, Pierre Teira, Mona Beaunoyer, Sonia Cournoyer, Élie Haddad, Gilles Vassal, Hervé Sartelet

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma

    Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma by Éric Raymond, Michel Fabbro, Valérie Boige, Olivier Rixe, Marc Frénay, Gilles Vassal, Sandrine Faivre, Evelyne Sicard, Caroline Germa, J.M. Rodier, Laurent Vernillet, Jean‐Pierre Armand

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models

    Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models by Estelle Daudigeos‐Dubus, Ludivine Le Dret, Claudia Lanvers‐Kaminsky, Olivia Bawa, Paule Opolon, Albane Vievard, Irène Villa, Mélanie Pagès, Jacques Bosq, Gilles Vassal, Dieter Zopf, Birgit Geoerger

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts

    Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts by Gilles Vassal, M J Terrier-Lacombe, Marie-Christine Bissery, A.M Vénuat, Fruzsina Gyergyay, Jean Bénard, Jackie Morizet, I Boland, P Ardouin, Brigitte Bressac–de Paillerets, Alain Gouyette

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer

    Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer by Gilles Vassal, Raphaël F. Rousseau, P. Blanc, Lucas Moreno, Gerlind Bode, S. Schwoch, Martin Schrappe, Jeffrey Skolnik, Lothar Bergman, M. Brigid Bradley‐Garelik, Vaskar Saha, Andy Pearson, H. Zwierzina

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: